GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests. The post GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion appeared first on Medical Device Network.
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
The post GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion appeared first on Medical Device Network.
